Delaware HB 62: AN ACT TO AMEND TITLE 6 OF THE DELAWARE CODE RELATING TO THE PROHIBITION OF EXCESSIVE AND UNCONSCIONABLE PRICES FOR PRESCRIPTION DRUGS.

Status: Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House (as of 2021-01-07)

State: Delaware · Session: 151 · Bill: HB 62

Subjects: Consumer Protection, Healthcare

Sponsors: Andria L. Bennett, Michael F. Smith, Trey Paradee, Bruce C. Ennis, Daniel B. Short, David Bentz, David P. Sokola, Debra Heffernan, Edward S. Osienski, Gerald L. Brady, John A. Kowalko, John L. Mitchell, Kendra Johnson, Kimberly Williams, Larry Lambert, Melissa Minor-Brown, Paul S. Baumbach, Sean M. Lynn, Sherry Dorsey Walker, Valerie Longhurst

View Delaware HB 62 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.